BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 36373605)

  • 41. Juvenile systemic lupus erythematosus: onset patterns and short-term outcome in Egyptian children, a single-center experience.
    Abdel-Hafez MA; Abdel-Nabi H
    Lupus; 2015 Nov; 24(13):1455-61. PubMed ID: 26223297
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical and serologic factors associated with lupus pleuritis.
    Mittoo S; Gelber AC; Hitchon CA; Silverman ED; Pope JE; Fortin PR; Pineau C; Smith CD; Arbillaga H; Gladman DD; Urowitz MB; Zummer M; Clarke AE; Bernatsky S; Hudson M; Tucker LB; Petty RE; ; Peschken CA
    J Rheumatol; 2010 Apr; 37(4):747-53. PubMed ID: 20110526
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluating the safety profile of calcineurin inhibitors: cancer risk in patients with systemic lupus erythematosus from the LUNA registry-a historical cohort study.
    Ichinose K; Sato S; Igawa T; Okamoto M; Takatani A; Endo Y; Tsuji S; Shimizu T; Sumiyoshi R; Koga T; Kawashiri SY; Iwamoto N; Tamai M; Nakamura H; Origuchi T; Yajima N; Sada KE; Miyawaki Y; Yoshimi R; Shimojima Y; Ohno S; Kajiyama H; Sato S; Fujiwara M; Kawakami A
    Arthritis Res Ther; 2024 Feb; 26(1):48. PubMed ID: 38347556
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Risk factors for damage in childhood-onset systemic lupus erythematosus in Asians: a case control study.
    Sit JKK; Chan WKY
    Pediatr Rheumatol Online J; 2018 Sep; 16(1):56. PubMed ID: 30201026
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mortality in a cohort of Egyptian systemic lupus erythematosus patients: A comparison with African, Arabic, and Mediterranean studies.
    Gamal S; Rady H; Sobhy N; Siam I; Soliman A; Elgengehy F
    Arch Rheumatol; 2023 Sep; 38(3):468-476. PubMed ID: 38046246
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Juvenile systemic lupus erythematosus: a single-center experience from southern Turkey.
    Balci S; Ekinci RMK; Bayazit AK; Melek E; Dogruel D; Altintas DU; Yilmaz M
    Clin Rheumatol; 2019 May; 38(5):1459-1468. PubMed ID: 30648229
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Predictors of improvement in disease activity in first hospitalized patients with systemic lupus erythematosus: a multicenter retrospective study of a Chinese cohort.
    Li M; Liang J; Pan W; Liu L; Wu M; Ding F; Hu H; Ding X; Wei H; Zou Y; Qian X; Wang M; Wu J; Tao J; Tan J; Da Z; Zhang M; Li J; Feng X; Wen L; Zhang H; Sun L
    Clin Rheumatol; 2022 Nov; 41(11):3355-3362. PubMed ID: 35849245
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Disease activity, severity, and damage in the UK Juvenile-Onset Systemic Lupus Erythematosus Cohort.
    Watson L; Leone V; Pilkington C; Tullus K; Rangaraj S; McDonagh JE; Gardner-Medwin J; Wilkinson N; Riley P; Tizard J; Armon K; Sinha MD; Ioannou Y; Archer N; Bailey K; Davidson J; Baildam EM; Cleary G; McCann LJ; Beresford MW;
    Arthritis Rheum; 2012 Jul; 64(7):2356-65. PubMed ID: 22294381
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Assessment of damage in juvenile-onset systemic lupus erythematosus: a multicenter cohort study.
    Ravelli A; Duarte-Salazar C; Buratti S; Reiff A; Bernstein B; Maldonado-Velazquez MR; Beristain-Manterola R; Maeno N; Takei S; Gerloni V; Spencer CH; Pratsidou-Gertsi P; Ruperto N; Pistorio A; Martini A
    Arthritis Rheum; 2003 Aug; 49(4):501-7. PubMed ID: 12910556
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Chinese Systemic Lupus Erythematosus Treatment and Research Group (CSTAR) Registry XI: gender impact on long-term outcomes.
    Zhang S; Ye Z; Li C; Li Z; Li X; Wu L; Liu S; Zuo X; Zhu P; Wang Z; Wang Y; Wang Z; Zhao J; Wang Q; Tian X; Li M; Zeng X
    Lupus; 2019 Apr; 28(5):635-641. PubMed ID: 30939980
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Post-COVID-19 depression and anxiety in patients with systemic lupus erythematosus.
    Abd El-Khalik DM; Eltohamy M
    Lupus; 2023 Jul; 32(8):974-982. PubMed ID: 37283176
    [TBL] [Abstract][Full Text] [Related]  

  • 52. An integrated extrapolation of long-term outcomes in systemic lupus erythematosus: analysis and simulation of the Hopkins lupus cohort.
    Watson P; Brennan A; Birch H; Fang H; Petri M
    Rheumatology (Oxford); 2015 Apr; 54(4):623-32. PubMed ID: 25234659
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prevalence of metabolic syndrome in a cohort of systemic lupus erythematosus patients from Northeastern Brazil: association with disease activity, nephritis, smoking, and age.
    Medeiros MM; Xavier de Oliveira ÍM; Ribeiro ÁT
    Rheumatol Int; 2016 Jan; 36(1):117-24. PubMed ID: 26149124
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Serum RANKL, osteoprotegerin (OPG) and RANKL/OPG ratio in children with systemic lupus erythematosus.
    Ali R; Hammad A; El-Nahrery E; Hamdy N; Elhawary AK; Eid R
    Lupus; 2019 Sep; 28(10):1233-1242. PubMed ID: 31403902
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Disease Damage Influences Cardiovascular Risk Reclassification Based on Carotid Ultrasound in Patients with Systemic Lupus Erythematosus.
    Quevedo-Abeledo JC; Rúa-Figueroa Í; Sánchez-Pérez H; Tejera-Segura B; de Vera-González A; González-Delgado A; Llorca J; González-Gay MÁ; Ferraz-Amaro I
    J Rheumatol; 2019 May; 46(5):483-491. PubMed ID: 30647175
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Difference in disease features between childhood-onset and adult-onset systemic lupus erythematosus.
    Brunner HI; Gladman DD; Ibañez D; Urowitz MD; Silverman ED
    Arthritis Rheum; 2008 Feb; 58(2):556-62. PubMed ID: 18240232
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The impact of obesity in systemic lupus erythematosus on disease parameters, quality of life, functional capacity and the risk of atherosclerosis.
    Rizk A; Gheita TA; Nassef S; Abdallah A
    Int J Rheum Dis; 2012 Jun; 15(3):261-7. PubMed ID: 22212605
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evolving phenotype of systemic lupus erythematosus in Caucasians: low incidence of lupus nephritis, high burden of neuropsychiatric disease and increased rates of late-onset lupus in the 'Attikon' cohort.
    Nikolopoulos D; Kostopoulou M; Pieta A; Karageorgas T; Tseronis D; Chavatza K; Flouda S; Rapsomaniki P; Banos A; Kremasmenou E; Tzavara V; Katsimbri P; Fanouriakis A; Boumpas DT
    Lupus; 2020 Apr; 29(5):514-522. PubMed ID: 32106788
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical and serological factors associated with lupus pericarditis: a case-control study.
    Hsieh MR; Chen YF; Chang CT; Yu KH; Fang YF
    Clin Rheumatol; 2023 Apr; 42(4):1061-1067. PubMed ID: 36495382
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Anti-dsDNA titre in female systemic lupus erythematosus patients: relation to disease manifestations, damage and antiphospholipid antibodies.
    Gheita TA; Abaza NM; Hammam N; Mohamed AAA; El-Gazzar II; Eissa AH
    Lupus; 2018 Jun; 27(7):1081-1087. PubMed ID: 29460701
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.